ENVERIC BIOSCIENCES, INC. (ENVB)

Every figure this model derived for ENVB, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2020-03-31.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 0 PaymentsToAcquirePropertyPlantAndEquipment 2023-12-31
cash 1,661,368 CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents 2020-12-31
current assets 8,793,325 AssetsCurrent 2026-06-30
current liabilities 861,475 LiabilitiesCurrent 2026-06-30
equity 8,082,524 StockholdersEquity 2026-06-30
revenue 38,831,007 Revenues 2020-03-31
sbc 0 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up ENVB on one particular measure came for.

RatioValue
current ratio10.21
current ratio reported10.21
growth cv1.42
revenue growth-8.89
revenue growth per share-8.89
sbc pct revenue0.0

What to be careful about

What this model itself distrusts about ENVB's figures. Written by the derivation as it ran, not added afterwards.